报道

订阅

MedSci主页 / 所有栏目 / 报道

非法疫苗案涉24省300名下线名单公布，你所在的地区中招了吗？

2016-03-22 新华社 新华社

疫苗危害
关注

原标题：山东省食药监局公布300条庞某等非法经营疫苗案线索 新华社济南3月19日电（记者王海鹰）根据济南市食品药品监督管理局在协助公安机关侦破庞某等非法经营疫苗案件中掌握的信息，山东省食品药品监督管理局共梳理出300条线索19日晚向社会公开。 这些线索包括向庞某等提供疫苗及生物制品的上线线索107条，从庞某等处购进疫苗及生物制品的下线线索193条。 对这些线索，山东省食药监局正在组织调查

原标题：山东省食药监局公布300条庞某等非法经营疫苗案线索

新华社济南3月19日电（记者王海鹰）根据济南市食品药品监督管理局在协助公安机关侦破庞某等非法经营疫苗案件中掌握的信息，山东省食品药品监督管理局共梳理出300条线索19日晚向社会公开。

这些线索包括向庞某等提供疫苗及生物制品的上线线索107条，从庞某等处购进疫苗及生物制品的下线线索193条。

对这些线索，山东省食药监局正在组织调查核查，发现违法行为将会同公安部门进行处理，对涉及外地有关线索已向当地进行了通报。（完）

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-23 1de8665bm23(暂无匿称)

    监管不力啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-23 milkshark

    好像没有

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-23 文医生

    监管部门在哪里

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-22 lyh994

    这么明确的线索，要不要收网？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-22 Dr.LV

    没人性！谁的错？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-22 jiangxianchen

    哎，不说了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=72855, encodeId=6c1ae28559c, content=监管不力啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Wed Mar 23 09:43:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72812, encodeId=f9aee28123c, content=好像没有, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Mar 23 06:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72783, encodeId=3d06e2783d7, content=监管部门在哪里, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4371683642, createdName=文医生, createdTime=Wed Mar 23 00:25:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72774, encodeId=5266e2774eb, content=这么明确的线索，要不要收网？, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Mar 22 23:39:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72730, encodeId=d7f6e273031, content=没人性！谁的错？, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Mar 22 18:09:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72718, encodeId=f030e27181b, content=哎，不说了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Mar 22 15:38:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72712, encodeId=9acce271211, content=什么人都有，没人性, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Tue Mar 22 15:02:00 CST 2016, time=2016-03-22, status=1, ipAttribution=)]
    2016-03-22 xyfg98

    什么人都有，没人性

    0

相关资讯

山东官方公布非法经营疫苗案查封疫苗品种名单

3月20日，山东食品药品监管部门经对警方提供的，关于庞某非法经营疫苗案查封疫苗品种的清单进行核实，发现实有疫苗12种、免疫球蛋白2种、治疗性生物制品1种。12种疫苗无第一类疫苗，全部为第二类疫苗，分别为冻干人用狂犬病疫苗(Vero细胞)、脊髓灰质炎灭活疫苗、b型流感嗜血杆菌结合疫苗、乙型脑炎减毒活疫苗、腮腺炎减毒活疫苗、冻干乙型脑炎灭活疫苗(vero细胞)、重组乙型肝炎疫苗(CHO细胞、汉逊酵母)

JAMA：美国拒绝接种疫苗的后果回顾

父母犹豫给儿童接种疫苗，可能会耽误常规的疫苗接种，或寻求免除接种国家疫苗方法。最近疫苗可预防的疾病在美国爆发引起了对这一现象的关注。提高对拒绝使用疫苗与这些疾病流行的关系的理解是有必要的。

美研发“戒烟疫苗” 助吸烟者戒除烟瘾

对许多吸烟者来说，戒烟通常是他们人生中的难事之一。据英国《每日邮报》3月10日报道，近日，美国的科学家通过研究发现，一种新型疫苗或许可以帮助吸烟者彻底戒除烟瘾。 美国加州斯克里普斯研究所(Scripps Institute in California)表示，他们已经研制了一种疫苗，可以减轻尼古丁对大脑的影响;这种疫苗可以增加尼古丁分子表面附着的抗体数量，延迟尼古丁发挥作用。 以前，吸烟者可以选

大量未经冷藏疫苗类产品流入多个省份 官方回应

食品药品监管总局已经责成山东省食品药品监管局会同公安和卫生计生部门，立即查清疫苗等相关产品的来源和流向，第一时间向社会公开相关信息。 澎湃新闻3月18日独家报道，山东省济南市公安机关破获一起法经营疫苗类产品案件，大量未经冷藏的疫苗类产品流入多个省份。国家食品药品监管总局官网18日晚就此发布消息称，总局新闻发言人表示，食品药品监管总局对此事件高度关注，已经责成山东省食品药品监管局会同公安和卫生计

AJOG：孕期接种百日咳疫苗的更佳时间

研究者对154名孕妇进行了一项前瞻性研究，探究孕期接种百日咳疫苗的最佳孕周时间窗口。参与者分为3组：未接种疫苗的对照组、早期疫苗接种组（孕28-32周）和晚期疫苗接种组（孕33-36周）。在疫苗接种前获取孕妇的静脉血样本，分娩时收集胎儿脐带血，检测血液中百日咳毒素 (PT)、百日咳杆菌粘附素(PRN)和百日咳丝状血凝素(FHA)的抗体水平。研究数据显示，三组孕妇血液中PRN和FHA抗体水平无差异，

寨卡疫苗已经在路上

寨卡病毒已经在几个热带地区造成很严重的健康问题，大部分病例发生在巴西。感染寨卡病毒之后最常见的症状就是发烧，皮疹，关节疼痛以及红眼。被病毒感染的伊蚊叮咬人类以后就会将病毒传递给人类，病毒颗粒随即进入人类血液。 寨卡病毒造成的最大威胁在于孕妇被病毒感染以后产下的孩子可能出现小头症（婴儿的头部畸形并存在脑部缺陷）。除此之外，寨卡病毒还可以通过性传播途径进行平行传递。 这些问题的出现意味着找到阻断疾